IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q4 2023 Holdings

Filed 2024-02-14 | 1 holdings | $550.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cyclerion Therapeutics Inc(CYCN)COM23255M204$550.8K164,429100.0%